Loading...
KRAS G12C lung adenocarcinoma represents a distinct group of patients with different response to immunotherapy
Masfarre, L. Rocha, P. Clave, S. Moliner, L. Navarro-Gorro, N. Rios-Hoyo, A. Sanchez, I. Giner, M. Corbera, A. Taus, A.
Masfarre, L.
Rocha, P.
Clave, S.
Moliner, L.
Navarro-Gorro, N.
Rios-Hoyo, A.
Sanchez, I.
Giner, M.
Corbera, A.
Taus, A.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Masfarré L, Rocha P, Clavé S, Moliner L, Navarro-Gorro N, Ríos-Hoyo A, et al. 167P KRAS G12C lung adenocarcinoma represents a distinct group of patients with different response to immunotherapy. Vol. 33, Annals of Oncology. Elsevier BV; 2022. p. S109.